Home
Therapeutic Categories
- BACK
- Therapeutic Categories
- Allergy & Immunology
  - BACK
  - Allergy & Immunology
  - Chronic Spontaneous Urticaria
  - Food Allergies
  - Pediatric Food Allergies
  - Search for:
- Dermatology
  - BACK
  - Dermatology
  - Atopic Dermatitis
  - Plaque Psoriasis
  - Search for:
- Endocrinology
  - BACK
  - Endocrinology
  - Type 2 Diabetes
  - Search for:
- Gastroenterology
  - BACK
  - Gastroenterology
  - Crohn's Disease
  - Ulcerative Colitis
  - Search for:
- Hematology
  - BACK
  - Hematology
  - Chronic Immune Thrombocytopenia
  - Paroxysmal Nocturnal Hemoglobinuria
  - Sickle Cell Disease
  - Search for:
- Hepatology
  - BACK
  - Hepatology
  - Liver Fibrosis
  - Search for:
- Infectious Diseases
  - BACK
  - Infectious Diseases
  - Adolescent Vaccinations
  - Adult Vaccinations
  - Influenza
  - Search for:
- Nephrology
  - BACK
  - Nephrology
  - IgAN
  - IgAN & C3G
  - Search for:
- Neurology
- Oncology
- Ophthalmology
  - BACK
  - Ophthalmology
  - Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
  - Search for:
- Osteoporosis
  - BACK
  - Osteoporosis
  - Osteoporosis
  - Search for:
- Psychiatry
  - BACK
  - Psychiatry
  - Major Depressive Disorder
  - Schizophrenia
  - Tardive Dyskinesia
  - Search for:
- Pulmonology
  - BACK
  - Pulmonology
  - Asthma
  - Chronic Obstructive Pulmonary Disease
  - Interstitial Lung Disease
  - Search for:
- Rheumatology
  - BACK
  - Rheumatology
  - Rheumatoid Arthritis
  - Systemic Lupus Erythematosus
  - Search for:
- Search for:
Conference Reporter
Expert Directory
About Expert Perspectives
Login/Register
Search for:

patient care perspectives

Elevated Counts and Thrombotic Risk in Patients With Polycythemia Vera

Elevated Counts and Thrombotic Risk in Patients With Polycythemia Vera

patient care perspectives
By Rami S. Komrokji, MD

Resistance or Intolerance to Hydroxyurea in Patients With Polycythemia Vera

Resistance or Intolerance to Hydroxyurea in Patients With Polycythemia Vera

patient care perspectives
By Ruben A. Mesa, MD, FACP

Early Identification of Patients With At-Risk Chronic Lymphocytic Leukemia

Early Identification of Patients With At-Risk Chronic Lymphocytic Leukemia

patient care perspectives

Understanding the Reasons for Chronic Lymphocytic Leukemia Therapy Discontinuation

Understanding the Reasons for Chronic Lymphocytic Leukemia Therapy Discontinuation

patient care perspectives
By Jennifer R. Brown, MD, PhD

Impact of Obesity and Comorbidity on Biologic Therapy Effectiveness

Impact of Obesity and Comorbidity on Biologic Therapy Effectiveness

patient care perspectives
By Jeffrey R. Curtis, MD, MS, MPH

Load More

2026 Expert Perspectives®

Privacy Policy Terms of Service About Expert Perspectives

Your California Privacy Rights Do Not Sell My Personal Information

Login Expert Perspectives

Forgot Password?

or Create an Account

Create an Account

Forgot Password?